Condition Strategy

Polypharmacy and Interaction Risk

Reduce medication-related adverse effects and interaction burden

Evidence Level A

Evidence and Risk Labels

Evidence A/B/C reflects research maturity, and risk levels reflect monitoring needs. These labels support comparison, not diagnosis or treatment decisions.

See full scoring guide

Guidance Summary

Medication-burden review and deprescribing frameworks are central for reducing adverse events in older adults with complex regimens.

Top Interventions

  • structured medication review
  • deprescribing where appropriate
  • interaction-aware supplement planning

Monitoring Priorities

  • medication count
  • interaction alerts
  • adverse event frequency
  • functional status

Source Links